Australia markets open in 9 hours 57 minutes

ABBV May 2022 97.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.45000.0000 (0.00%)
As of 03:26PM EST. Market open.
Full screen
Previous close0.4500
Open0.5700
Bid0.0000
Ask0.0000
Strike97.50
Expiry date2022-05-20
Day's range0.4500 - 0.5700
Contract rangeN/A
Volume14
Open interest728
  • PR Newswire

    Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX® Cosmetic Story. The company continues its commitment to showcase real people and real stories as part of its larger mission to create a more inclusive and authentic dialogue around the decision to receive aesthetic treatments. Building on the success of the original 'See Yourself' campaign, launched in 2021, BOTOX® Cosmetic, is launching

  • Motley Fool

    What This FDA News Could Mean for AbbVie's Stock

    Earlier this month, AbbVie (NYSE: ABBV) completed its application to the U.S. Food and Drug Administration (FDA) for Rinvoq to treat adults with a back arthritis (known as non-radiographic axial spondyloarthritis) who previously tried nonsteroidal anti-inflammatory drugs (NSAIDs) but did not benefit. If eventually approved by the FDA, this would be the fourth approved indication in the U.S. for Rinvoq. Let's take a look at Rinvoq's efficacy in treating patients with this form of back arthritis and the sales potential of the indication for pharma stock AbbVie.

  • Motley Fool

    Is AbbVie Stock a Top Pick for 2022?

    Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.